Trial Profile
An open label randomized controlled trial on the preemptive risedronate intervention for renal transplant patients receiving glucocorticoid
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 09 May 2017
Price :
$35
*
At a glance
- Drugs Risedronic acid (Primary) ; Vitamin D
- Indications Corticosteroid-induced osteoporosis; Metabolic bone diseases
- Focus Therapeutic Use
- Acronyms PRIUS-RTx Study
- 06 Sep 2013 New trial record